Chronic cough, a prevalent and often vexing condition, poses significant diagnostic and therapeutic challenges for clinicians. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough, with a focus on evidence-based practices and recent advances in the field.
Diagnosing chronic cough requires a systematic approach that involves a thorough patient history and physical examination. The clinician should consider common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, less common etiologies like bronchogenic carcinoma or foreign body aspiration must also be considered. Diagnostic tools such as chest X-rays, spirometry, and bronchoscopy can facilitate the identification of the underlying cause.
Management of chronic cough should be tailored to the identified cause. For example, GERD-related cough may respond to proton pump inhibitors, while inhaled corticosteroids may be beneficial for cough variant asthma. For idiopathic chronic cough, recent studies suggest that speech therapy may be an effective intervention. It is also essential to reassess and adjust the treatment plan regularly based on the patient's response.
Recent advancements have led to the identification of novel cough biomarkers and the development of new antitussive drugs. For instance, P2X3 antagonists have shown promising results in clinical trials for refractory chronic cough. Additionally, the role of cough hypersensitivity syndrome in chronic cough is gaining recognition, opening new avenues for therapeutic interventions.
Chronic cough is a complex clinical entity that requires a comprehensive and individualized approach to diagnosis and management. Understanding the common and uncommon causes, employing a systematic diagnostic approach, and staying abreast of emerging trends can help clinicians effectively manage this challenging condition. Continuous research and innovation in this field promise to bring new insights and improved patient outcomes in the future.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation